Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials-Reference-Cited by-同舟云学术

Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials

Published:2019-12-02 Issue:4 Volume:27 Page:609-618
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Ruff D. D.¹,Ford J. H.¹,Tockhorn‐Heidenreich A.²,Stauffer V. L.¹,Govindan S.³^ORCID,Aurora S. K.¹,Terwindt G. M.⁴,Goadsby P. J.⁵

Affiliation:

1. Eli Lilly and Company Indianapolis IN USA

2. Eli Lilly and CompanyErl Wood Manor Windlesham UK

3. Eli Lilly Services India Private Limited Bengaluru India

4. Leiden University Medical Center Leiden The Netherlands

5. NIHR‐Wellcome Trust King’s Clinical Research Facility SLaM Biomedical Research Centre King’s College London London UK

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.14114

Reference25 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

2. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

3. My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed

4. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

5. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of galcanezumab in chronic and episodic migraine patients: a systematic review and meta-analysis of randomized controlled trials;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2024-05-13

2. Crowdsourcing adverse events associated with monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) signaling for migraine prevention: Natural language processing analysis of social media (Preprint);JMIR Formative Research;2024-03-08

3. Effectiveness of Switching CGRP Monoclonal Antibodies in Non-Responder Patients in the UAE: A Retrospective Study;Neurology International;2024-02-18

4. Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY);Neurology and Therapy;2024-02-08

5. Migraine Preventive Treatment Failure: A Cross-Sectional Study in a Tertiary Center in Brazil;Headache Medicine;2023-12-29